Pfizer to buy weight-loss drug developer Metsera for up to $4.9 billion
Pfizer to buy weight-loss drug developer Metsera for up to $4.9 billionhttps://wpnnradio.com/wp-content/themes/movedo/images/empty/thumbnail.jpg150150adminadminhttps://secure.gravatar.com/avatar/790df65a416873c3f0501d984b0b24a2f32bf2af0d1509085b901ade4bbb36e7?s=96&d=mm&r=g
(Reuters) -Pfizer said on Monday it would acquire weight-loss drug developer Metsera for up to $4.9 billion to secure its position in the lucrative obesity treatment market.
(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)
